Enfusion, Inc (ENFN) Misses Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts ENFN Hot Sheet
Join SI Premium – FREE
Enfusion, Inc (NYSE: ENFN) reported Q3 EPS of $0.05, $0.01 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $51.17 million versus the consensus estimate of $52.17 million.
For earnings history and earnings-related data on Enfusion, Inc (ENFN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Bath & Body Works to Buy with $25 price target
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
